What question did this study set out to answer?

This review aims to provide an overview of the diagnostics and treatments of systemic light-chain amyloidosis, underscoring challenges and advancements.

June 10, 2026CA A Cancer Journal for CliniciansOpen Access

Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates

View Full Paper

Ask AI

Bookmark

Authors

XWXia WuTufts Medical Center HLHeather LandauMemorial Sloan Kettering Cancer Center JLJennifer E. LiuMemorial Sloan Kettering Cancer Center

Discussion

Member takes

Implication

Review highlights diagnostic challenges and therapeutic updates in systemic amyloid light-chain amyloidosis, indicating significant management improvements.

Key Points

This review aims to provide an overview of the diagnostics and treatments of systemic light-chain amyloidosis, underscoring challenges and advancements.
Summary of pathobiology, diagnosis, and management of systemic light-chain amyloidosis.
Discussion of diagnostic algorithms and response assessment techniques.
Evaluation of emerging treatments and their implications for patient management.
Daratumumab-based regimens have significantly improved frontline therapy outcomes.
Advancements in cytogenetic profiling and measurable residual disease assessment aid in risk-adapted management.
Therapeutic developments like BCL-2-targeted therapy and CAR T-cell therapy expand treatment options.

Cite This Study

Wu et al. (2026) studied this question.

synapsesocial.com/papers/6a2901e26f82f25be989de7f https://doi.org/10.3322/caac.70092

View Full Paper

Ask AI

Bookmark

Implication

Review highlights diagnostic challenges and therapeutic updates in systemic amyloid light-chain amyloidosis, indicating significant management improvements.

Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates

Discussion

Member takes

Implication

Key Points

Cite This Study

Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider